RiverStone Health encourages everyone to receive the updated COVID-19 vaccine as recommended by the Centers for Disease ...

This World Immunisation Week (24–30 April 2025), people across the West Midlands are being urged to check that they are up to ...

Amid everything from the COVID-19 pandemic to recent upswells of influenza and RSV, vaccines have become as common a ...

The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring ...

Pfizer's Abrysvo and GSK's Arexvy both received FDA-approval b in 2024 to include immunization of adults aged 50 to 59 years at increased risk for RSV disease.

There are two vaccines approved by the FDA -- RotaTeq and Rotarix -- that protect against rotavirus, the most common cause of ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted on recommendations for several ...

Among the many contagious diseases circulating right now — RSV, walking pneumonia and norovirus among ... and the cases will ...

Arexvy, already approved in over 60 countries, was supported by trial data showing safety and immune response in the 50–59 age group. GSK said more than 13 million adults in the US fall into this ...

A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis.

The CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...